Multidrug efflux pumps are found in all major transporter families. Along with a lack of three-dimensional structure information, the mechanism of drug recognition, energy coupling with drug translocation and the catalytic cycle are so far not understood. In the present study, we present first data of a fluorescence-based assay to study the pH-gradient-mediated activity of the multidrug antiporter EmrE, by co-reconstitution with the light-driven proton pump bacteriorhodopsin. In addition to biochemical approaches, the emerging technique, solid-state NMR, can be used for the investigation of these transporters. A number of experiments based on MAS (magic angle sample spinning) NMR are available to provide data on protein structure and dynamics, drug binding and protein-lipid interactions. However, these experiments dictate a number of constraints with respect to sample preparation that will be discussed for proteins from the SMR (small multidrug resistance transporter) family. In addition, 2 H-NMR is used to probe protein mobility of Lactococcus lactis ABC transporter, LmrA.
porters and therefore, excellent model systems. Despite a number of biochemical and biophysical studies on one of these proteins, E. coli EmrE, the nature of drug recognition, the catalytic transport cycle, structure and structural changes are still an area of debate. Furthermore, other members of the SMR family (E. coli SugE, YdgE/YdgF, Halobacterium salinarium Hsmr, Mycobacterium tuberculosis Tbsmr, Salmonella typhimurium Yfbw) show certain sequence homology but very different drug recognition and transport characteristics making a comparative investigation sensible. In all cases, a protonmotive force seems to be required for drug translocation. However, it is not clear to what extent a pH gradient and/or a charge gradient will contribute as both charged and non-charged substrates are transported.
Functional studies: a linked EmrE-br (bacteriorhodopsin) assay
To address this problem, a suitable transport and/or binding assay is necessary. It is also essential to monitor protein activity during sample preparation screens as SSNMR itself poses sample preparation restrictions (see below). In the case of the multidrug transporters in general and SMR proteins in particular, good assays provide a challenge due to the nature of the substrates. Many studies have used binding assays performed on detergent solubilized protein [3] [4] [5] . These are not ideal since a protein may bind a substrate without completing its reaction cycle. Schuldiner and co-workers have developed radioisotope-based pumping assays [3, 4, 6] . However, whilst these assays do demonstrate pumping, they are time consuming to perform, have very low time resolution and suffer from the fact that it is difficult to maintain a pH gradient across a membrane due to the permeable nature of membranes to protons. Some groups have attempted to utilize the fact that ethidium bromide is a substrate for many SMR proteins and that ethidium bromide fluorescence intensity is greatly increased on binding to DNA [7, 8] . Thus DNA was trapped inside liposomes, an SMR protein was incorporated into the liposomes and then ethidium bromide was added to the system. Following this, the pH of the external buffer was rapidly raised. The SMR protein should then pump the ethidium bromide into the vesicles, where it binds to DNA resulting in a concomitant change in the emission spectrum of ethidium bromide. However, the first publication of the ethidium bromide-based EmrE assay makes no mention of DNA inside the liposomes [9] . Furthermore, control experiments performed in our laboratory and also in other laboratories have shown that the observed change in ethidium bromide fluorescence is independent of the presence of DNA in the liposome (K. Charalambous and P. J. Booth, personal communication) [10] . The question then remains, what is causing the change on ethidium bromide fluorescence? With the systems described above, it is difficult to answer this question since the liposomes are permeable to protons and hence the proton gradient cannot be maintained over the course of an experiment.
To address this issue, we have co-reconstituted the light driven proton pump br and the SMR antiporter EmrE into the same vesicle: br generates a proton gradient across the membrane which is used by EmrE for drug translocation (Figure 1 , top). The process was followed by monitoring ethidium bromide fluorescence. EmrE was prepared as described by Curnow et al. [7] and reconstituted into total E. coli polar lipid extract. Using the freeze-thaw/sonication method [11] br was incorporated into the EmrE proteoliposomes. This results in an approx. 90 % inside out orientation of all br in the vesicle causing a lightinduced pH that corresponds to an alkalinization of the external solution. The resulting proteoliposomes consisted of lipid/br/EmrE at approximate molar ratios of 1800:3:1 for the highest EmrE concentration used. The fluorescence measurements were performed on 150 µl of proteoliposomes diluted into 2 ml of 150 mM KCl, 2 mM EDTA (pH 6.9) and the appropriate concentration of ethidium bromide. The mixture was incubated in the dark at 25
• C for 10 min. The pumping assay was initialized by opening the excitation shutter of the fluorimeter and starting the measurement simultaneously. An excitation wavelength of 545 nm (10 nm bandwidth) was used. This wavelength excites both the ethidium bromide and the br, causing it to pump protons. The emission intensity at 610 nm (5 nm bandwidth) was collected until a steady state was reached. The excitation shutter was then closed and the system left to equilibrate for 5-10 min. The experiment was repeated by once again opening the excitation shutter. Measurements were repeated up to eight times. All measurements were performed at 25
• C. The change in ethidium bromide emission intensity measured over time is shown in the inset of Figure 1 for an agent used to abolish membrane integrity, collapses the proton gradients, resulting in no change in fluorescence intensity (c). These time-resolved traces are highly reproducible; after equilibration in the dark, initial fluorescence intensity is consistent and independent of the number of times the experiment has been performed (solid and broken lines).
The total change in intensity is dependent on ethidium bromide concentration as shown in the main plot of Figure 1 . Our data fit to a one site binding equation yielding a dissociation constant K d of 4.2 µM. This is comparable with the 5 µM obtained from isothermal titration calorimetry measurements [12] . The absolute deflection in fluorescence intensity is also dependent on EmrE concentration.
Combined, these data suggest that the change in ethidium bromide fluorescence is reporting on a pH-gradient-dependent ethidium bromide/EmrE binding event. The amount of EmrE present in the sample is the amplitude-limiting factor for drug translocation. While a detailed quantification requires further studies, our data already show that the suggested fluorescence/light-driven pH gradient system based on co-reconstituting br with the antiporter EmrE forms the foundations of a robust and novel binding/transport assay.
Challenges and opportunities of applying SSNMR spectroscopy to transporters
Beyond functional studies and in addition to crystallization approaches to elucidate the 3D (three-dimensional) structures of multidrug transporters, SSNMR can provide detailed insight into structural organization and dynamical properties of these systems. A great advantage that SSNMR has over other means of studying membrane proteins is that it can be used in a plethora of states. Whilst diffraction methods are limited to studying 2D or 3D crystals and solution NMR must use proteins solubilized (with detergent or organic solvents) in poor membrane mimetic environments, SSNMR may utilize all of the above states along with protein reconstituted into lipid bilayers. This offers the possibility to apply an activity assay directly to the sample being measured. Furthermore, investigations of the dynamics of the protein as it binds ligands [13] , negotiates its reaction cycle [14] or responds to changes in the lipid environment are possible [15] .
So far, SSNMR applications on transporters have mainly addressed the problem of substrate-protein interactions [13, 16, 17] 15 N spectrum during an overnight measurement requires more than 0.2 µmol of protein. 2D experiments demand even greater quantities in excess of 1 µmol. Given then that the active volume of a standard SSNMR 4 mm MAS (magic angle sample spinning) rotor is in the order of 50-70 µl, the protein concentration must be in the order of 3-20 mM which means that 2-10 mg of a small 12 kDa membrane protein such as EmrE has to fit into a MAS rotor. In the case of proteoliposomes, the difficulty of getting a large quantity of protein into the rotor is compounded by the presence of lipids. In this laboratory, protein is routinely reconstituted at molar protein/lipid ratios of 1:100, that is the highest before seriously risking aggregation. This can result in approx. fourfifths of the volume of the rotor being taken up by lipids. The large amount of protein required for SSNMR experiments necessitates an efficient expression and purification system. Furthermore, it is vital that a range of isotope labels can be incorporated into the protein whilst minimizing the risk of label scrambling and dilution. Understanding the structure and function of multidrug efflux pumps will require both uniform and amino acid-selective isotope-labelling scheme [14, 18] . The latter is especially useful to address site-specific questions and can be performed using for example certain E. coli or L. lactis strains [19] . Alternatively, semicontinuous cell-free expression using a coupled transcription and translation system can be utilized and has been demonstrated to express integral membrane proteins to levels required for NMR [8] . This prokaryotic, coupled in vitro transcription and translation system exploits T7 RNA polymerase for targeted transcription of genes under the control of a T7 promoter. This method offers full control over the expression conditions for uniform and specific isotope labelling and also enables the use of detergents and liposomes to provide a membrane-mimetic environment for expressed membrane proteins. Additional benefits of cell-free expression are low detergent and specific labelling costs. Using this approach, we have successfully overexpressed a number of SMR proteins (from E. coli EmrE, SugE, YdgF; from H. salinarium Hsmr; from M. tuberculosis Tbsmr; and from S. typhimurium Yfbw) at quantities required for NMR.
Finding ideal reconstitution conditions has required screening of several methods for removing the excess detergent (dialysis, biobeads, rapid dilution) as well as testing numerous other factors including the initial solubilizing detergent, final lipid composition and physical parameters such as pH and salt concentration. Successful reconstitution is routinely checked by sucrose density gradients, freeze fracture electron microcopy and fluorescence assays. First, NMR experiments have been performed on EmrE, SugE, TBsmr and Hsmr.
An example spectrum for EmrE is shown in Figure 2 (a). Throughout the SMR family, the residue Glu 14 is highly conserved and involved in drug binding [20] . Residue specific 13 C labelling of glutamic acid would allow characterization of the protonation state and drug-protein interactions. However, this labelling is only possible using the cell-free approach. The 13 C-CP-MAS ( 13 C-cross-polarization MAS) spectrum in the upper plot of Figure 2 (a) demonstrates a common problem that is encountered when acquiring spectra of proteoliposomes: the large 13 C natural abundance background of lipid and protein obscures all resonances from the labelled sites. One solution would be to use double-quantum filtering techniques (Figure 2a, bottom) to suppress all unwanted background resonances. Our spectra in Figure 2(a) demonstrate the feasibility of expression, labelling and reconstitution concepts. However, sample preparation requires further screening to optimize the linewidth of the spectra obtained. An alternative to reconstitution is given under certain circumstances by preparing 3D micro-or nanocrystals of membrane proteins as shown for diacylglycerol kinase [18] . While this removes many of the advantages gained from studying proteoliposomes, it may allow production of highly concentrated and structurally homogeneous samples.
In addition to proteins from the SMR family, also larger ABC multidrug transporters are now available for detailed SSNMR studies [21] . Here, we report the first 2 H-NMR experiments to probe the mobility of 64 kDa L. lactis efflux pump LmrA, a functional homologue of P-glycoprotein [22] . The protein has been prepared as described previously [21] . Residue-specific labelling was achieved by adding Ala-d 3 to the defined medium used for bacterial growth. In total, 48 alanine residues are distributed along the LmrA sequence with 20 in the nucleotide binding domains. As shown in Figure 2 (b), a typical 2 H-Pake pattern is obtained at low temperature (230 K) indicating that the protein backbone is immobile on the 2 H-NMR timescale. However, raising the temperature to 4
• C, the spectrum splits into two components. The more narrow isotropic line arises from protein segments with higher mobility, which causes a reduction in the 2 H quadrupole coupling. Treating the LmrA proteoliposomes with proteinase K to cleave off the nucleotide binding domains results in a reduction of this narrow spectral component. We can conclude from these data that the nucleotide binding domains are far more mobile than the transmembrane domain of the transporter. Further studies are in progress and will be reported elsewhere (A. Siarheyeva, H. van Veen and C. Glaubitz, unpublished work).
Conclusions and perspective
Bacterial multidrug efflux pumps from the SMR and ABC transporter families are exciting but very challenging targets for detailed SSNMR studies. A novel assay based on coreconstitution of br and EmrE has been demonstrated. Cellfree expression of SMR proteins allows isotope labelling schemes that are difficult to perform using cell-based systems as shown for EmrE. First results of 2 H-NMR from the ABC transporter LmrA reveal significant motional differences between a transmembrane domain and nucleotide binding sites.
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